Changes

Jump to: navigation, search

Speculative timeline of future malaria events

3 bytes added, 06:25, 17 November 2019
no edit summary
| 2024 || Vaccine || The Global Malaria Vaccines Market, by Vaccine Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine), by Agent (''{{w|Plasmodium Falciparum}}'', ''{{w|Plasmodium Vivax}}''), and by Distribution Channel (Hospitals, Clinics, Community Centers) is expected to be valued at US$ 50.6 million in this year.<ref name="nbc29.com">{{cite web |title=At 150.0% CAGR, Malaria Vaccines Market to Surge past US$ 790.7 Million by 2027 | Key Findings, Regional Analysis, and Key Players GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biot |url=https://www.nbc29.com/story/40957707/at-1500-cagr-malaria-vaccines-market-to-surge-past-us-7907-million-by-2027-key-findings-regional-analysis-and-key-players-glaxosmithkline-plc-sanaria |website=nbc29.com |accessdate=17 November 2019}}</ref> || || || Estimate || August, 2019
|-
| 2024 || Vaccine || {{w|RTS,S/AS01}} (trade name Mosquirix) is expected to be marketed in this year.<ref name="nbc29.com"/> || || || Project || August, 2019
|-
| 2030 || Eradication || Indonesia aims to become malaria-free by this year.<ref name="West Java aims to be malaria-free by 2022"/> || {{w|Indonesia}} || {{w|Government of Indonesia}} || Project || 2008
62,434
edits

Navigation menu